An interventional study of self-myofascial stretching and conventional physical therapy in Patients With Stage I and II Carpal Tunnel Syndrome, sponsored by Imam Abdulrahman Bin Faisal University. Completed at 1 site in India. Open to participants aged 30 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-12-17.
Sponsored by Imam Abdulrahman Bin Faisal University · Not applicable, Interventional, and Treatment
Background/Objectives: Carpal tunnel syndrome (CTS), a median mononeuropathy from nerve compression in the wrist's carpal tunnel, will be studied to compare self-myofascial carpal ligament stretching plus conventional physical therapy versus physical therapy alone for pain reduction and function improvement in stage I/II CTS patients.
Methods: Thirty-six eligible stage I/II CTS patients will be randomized (18/group). The experimental group will receive self-myofascial stretching + conventional therapy; controls will get conventional therapy only. Treatment will last 6 weeks; outcomes will be assessed via Boston Carpal Tunnel Questionnaire and Visual Analogue Scale.
Imam Abdulrahman Bin Faisal University is the lead sponsor of 88 studies on the registry; 14 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Diagnosed CTS, stage I/II (EMG-confirmed).
Age 30-60 years.
Both genders.
Dominant hand (unilateral/bilateral).
English literate.
Exclusion Criteria:
Polyneuropathy.
Adaptive equipment use.
Shoulder pathologies.
Other neurological/musculoskeletal conditions.
Recent carpal tunnel release (\<1 year).
Other: self-myofascial stretching
Other: conventional physical therapy
self-myofascial stretching exercise
conventional physical therapy treatment, including exercises
Boston Carpal Tunnel Questionnaire
Used to assess the function of carpals
Time frame: 6 weeks
Visual Analogue Scale
Involves asking participants to rate their current level of pain on a scale from 0= No pain to 10= maximum pain is felt.
Time frame: 6 weeks
This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Imam Abdulrahman Bin Faisal University